Novo Nordisk Aktie
64,08
EUR
-1,30
EUR
-1,99
%
60,86
CHF
-0,68
CHF
-1,11
%
Werbung
Novo Nordisk Aktie Analyse
11.06.19 | Novo Nordisk buy | UBS AG | |
11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.05.19 | Novo Nordisk buy | UBS AG | |
06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
Werbung
|
|||
03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | UBS AG | |
29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
01.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
10.12.18 | Novo Nordisk buy | Deutsche Bank AG | |
30.11.18 | Novo Nordisk buy | UBS AG | |
26.11.18 | Novo Nordisk buy | UBS AG | |
23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.11.18 | Novo Nordisk buy | UBS AG | |
02.11.18 | Novo Nordisk buy | Deutsche Bank AG | |
02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
01.11.18 | Novo Nordisk buy | UBS AG | |
26.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.10.18 | Novo Nordisk buy | UBS AG | |
10.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.10.18 | Novo Nordisk buy | Deutsche Bank AG | |
05.10.18 | Novo Nordisk buy | UBS AG | |
04.10.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
20.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung